Successful implementation and results of an HPV vaccination program in Geneva Canton, Switzerland
- PMID: 25931623
- PMCID: PMC4388217
- DOI: 10.1177/003335491513000306
Successful implementation and results of an HPV vaccination program in Geneva Canton, Switzerland
Abstract
We describe a human papillomavirus (HPV) vaccination program implemented since 2007 in Geneva Canton, Switzerland, that used school services, a public hospital, and private physicians as vaccination providers. We assessed program performance with the evolution of immunization coverage during the first four years of program implementation. We measured vaccination coverage of the target population using individual records of vaccination status collected by service providers and transmitted to the Geneva Canton Medical Office. The target population was 20,541 adolescent girls aged 11-19 years as of September 1, 2008, who resided in the canton when the program began. As of June 30, 2012, HPV vaccination coverage was 72.6% and 74.8% in targeted cohorts for three and two doses, respectively. The global coverage for three doses increased by 27 percentage points from December 2009 to June 2012. Coverage for girls aged 16-18 years at the beginning of the program reached 80% or more four years into the program. High coverage by this HPV vaccination program in Geneva was likely related to free vaccination and easy access to the vaccine using a combination of delivery services, including school health services, a public hospital, and private physicians, covering most eligible adolescent girls.
Similar articles
-
Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.Aust N Z J Public Health. 2009 Aug;33(4):365-70. doi: 10.1111/j.1753-6405.2009.00409.x. Aust N Z J Public Health. 2009. PMID: 19689598
-
Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign.Glob Health Sci Pract. 2018 Oct 4;6(3):425-438. doi: 10.9745/GHSP-D-18-00090. Print 2018 Oct 3. Glob Health Sci Pract. 2018. PMID: 30143561 Free PMC article.
-
[Factors associated with HPV immunization for 13-14-year-old girls in the Geneva district, Switzerland].Rev Epidemiol Sante Publique. 2013 Dec;61(6):513-8. doi: 10.1016/j.respe.2013.07.683. Epub 2013 Oct 25. Rev Epidemiol Sante Publique. 2013. PMID: 24206904 French.
-
Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program.Vaccine. 2014 Jan 9;32(3):320-6. doi: 10.1016/j.vaccine.2013.11.070. Epub 2013 Dec 2. Vaccine. 2014. PMID: 24295804 Review.
-
Human papillomavirus vaccine introduction--the first five years.Vaccine. 2012 Nov 20;30 Suppl 5:F139-48. doi: 10.1016/j.vaccine.2012.05.039. Vaccine. 2012. PMID: 23199957 Review.
Cited by
-
Gender-Neutral HPV Vaccine in India; Requisite for a Healthy Community: A Review.Cancer Control. 2024 Jan-Dec;31:10732748241285184. doi: 10.1177/10732748241285184. Cancer Control. 2024. PMID: 39344048 Free PMC article. Review.
-
Characteristics of HPV-unvaccinated undergraduate health students in Switzerland, a cross sectional study.Arch Public Health. 2019 Jun 18;77:29. doi: 10.1186/s13690-019-0348-y. eCollection 2019. Arch Public Health. 2019. PMID: 31236272 Free PMC article.
-
Prevalence of Vaccine Type Infections in Vaccinated and Non-Vaccinated Young Women: HPV-IMPACT, a Self-Sampling Study.Int J Environ Res Public Health. 2018 Jul 9;15(7):1447. doi: 10.3390/ijerph15071447. Int J Environ Res Public Health. 2018. PMID: 29987255 Free PMC article.
-
A systematic literature review of human papillomavirus vaccination strategies in delivery systems within national and regional immunization programs.Hum Vaccin Immunother. 2024 Dec 31;20(1):2319426. doi: 10.1080/21645515.2024.2319426. Epub 2024 Feb 27. Hum Vaccin Immunother. 2024. PMID: 38410931 Free PMC article.
-
Worldwide initiatives to eliminate cervical cancer.Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):102-106. doi: 10.1002/ijgo.13879. Int J Gynaecol Obstet. 2021. PMID: 34669201 Free PMC article.
References
-
- Berchtold A, Michaud PA, Nardelli-Haefliger D, Suris JC. Vaccination against human papillomavirus in Switzerland: simulation of the impact on infection rates. Int J Public Health. 2010;55:25–34. - PubMed
-
- World Health Organization. Report of the consultation on human papillomavirus vaccines. Geneva: WHO; 2005. Also available from: URL: http://whqlibdoc.who.int/hq/2005/WHO_IVB_05.16.pdf [cited 2013 May 7]
-
- Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol. 2006;107:1018–22. - PubMed
-
- University of Geneva. Geneva: University of Geneva; 2009. [Cancer in Geneva: incidence, mortality, survey, and prevalance, 2003–2006] Also available from: URL: http://www.unige.ch/medecine/rgt/publicationquadriennale/publication_197... [cited 2013 Jun 10]
-
- Lugarini J, Maddalo F. Results of a vaccination campaign against human papillomavirus in the province of La Spezia, Liguria, Italy, March–December 2008. Euro Surveill. 2009;14:19342. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials